BIO-key International (NASDAQ:BKYI) Posts Quarterly Earnings Results, Misses Estimates By $0.18 EPS

BIO-key International (NASDAQ:BKYI) announced its earnings results on Thursday. The technology company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.18), Zacks reports. The business had revenue of $1.46 million for the quarter, compared to the consensus estimate of $2.29 million. BIO-key International had a negative net margin of 72.53% and a negative return on equity of 3,124.77%.

BIO-key International Stock Down 4.9 %

Shares of NASDAQ BKYI opened at $0.81 on Friday. The firm has a fifty day simple moving average of $1.20 and a two-hundred day simple moving average of $1.15. BIO-key International has a 12 month low of $0.52 and a 12 month high of $3.68. The company has a current ratio of 0.78, a quick ratio of 0.71 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $2.54 million, a PE ratio of -0.36 and a beta of -0.10.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.